Cited by 1,428HIV/AIDS Research and InterventionsMedication Adherence and ComplianceHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., PATIENT CARE COMMITTEE & ADHERENCE·2000·AIDS Care

DOI 10.1080/09540120050042891

Open this paper in CoChat — free account

Abstract

This paper describes the AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG). The questionnaires were administered to 75 patients at ten AACTG sites in the USA. All patients were taking combination antiretroviral therapy (ART), including at least one protease inhibitor. Eleven per cent of patients reported missing at least one dose the day before the interview, and 17% reported missing at least one dose during the two days prior. The most common reasons for missing medications included 'simply forgot' (66%) and a number of factors often associated with improved health, including being busy (53%), away from home (57%) and changes in routine (51%). Less adherent patients reported lower adherence self-efficacy (p = 0.006) and were less sure of the link between non-adherence and the development of drug resistance (p = 0.009). They were also more likely to consume alcohol, to be employed outside the home for pay and to have enrolled in clinical trials to gain access to drugs (all p < 0.05). Twenty-two per cent of patients taking drugs requiring special instructions were unaware of these instructions. Each questionnaire took approximately ten minutes to complete. Responses to the questionnaires were favourable. These questionnaires have been included in six AACTG clinical trials to date and have been widely disseminated to investigators both in the USA and abroad.

Integrity signals

Registry

Crossref · 10.1080/09540120050042891

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Survey Research Methods.
Hesselbart, S., & Fowler, F. J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288598 · Cited by 4,767
Compliance in Health Care
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Age and Depression
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 856
Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease Inhibitors
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B. A., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 443
Self-citation
Patient Compliance and Drug Failure in Protease Inhibitor Monotherapy
Vanhove, G. F. (1996) · JAMA · doi:10.1001/jama.1996.03540240033024 · Cited by 193
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Compliance in clinical trials
Besch, C. L. (1995) · AIDS · doi:10.1097/00002030-199501000-00001 · Cited by 148
Predictors of patient adherence: Patient characteristics.
Dunbar, J. (1990) · Cited by 83

Show all 12 references

Sorted by citations

Items 701–800 of 1,001

The Role of Alcohol on Antiretroviral Therapy Adherence Among Persons Living With HIV in Urban India
Schensul, S. L., Ha, T., Schensul, J. J., Vaz, M., Singh, R., Burleson, J. A., & BRYANT, K. J. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.716 · Cited by 27
“ART adherence was assessed retrospectively based on a 4-day recall using the AIDS Clinical Trials Group instrument (Chesney et al., 2000).”
Method
Association between Medication Adherence Outcomes and Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus-Positive Patients
Radhakrishnan, R. K., Sonika, S. S., Sudha, V., & Varma, D. M. (2012) · Journal of Young Pharmacists · doi:10.4103/0975-1483.104369 · Cited by 27
“The AIDS Clinical Trail Group (ACTG) adherence questionnaire[5] was used for medication adherence assessment.”
Method
Placebo Practice Trials: The Best Predictor of Adherence Readiness for HAART Among Drug Users?
Glenn, W. (2003) · HIV Clinical Trials · doi:10.1310/yvtr-t8ev-3tq6-qajc · Cited by 27
Medication Management Skill in HIV: I. Evidence for Adaptation of Medication Management Strategies in People with Cognitive Impairment. II. Evidence for a Pervasive Lay Model of Medication Efficacy
Albert, S. M., Flater, S. R., Clouse, R., Todak, G. G., Stern, Y., & Marder, K. S. (2003) · AIDS and Behavior · doi:10.1023/a:1025404105378 · Cited by 27
“Nonadherers were less likely to recognize the relationship between adherence and drug resistance and were often unaware of special medication management instructions (Chesney et al., 2000).”
Background
Correlation of a Brief Perceived Stress Measure With Nonadherence to Antiretroviral Therapy Over Time
French, T., Weiss, L., Waters, M., Tesoriero, J. M., Finkelstein, R., & Agins, B. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000135960.88543.8d · Cited by 27
Feasibility Testing of a Web-Based Symptom Self-Management System for Persons Living With HIV
Schnall, R., Wantland, D. J., Vélez, O., Cato, K., & Jia, H. (2014) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2013.09.002 · Cited by 26
Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol
Bezabhe, W. M. M., Peterson, G. M., Bereznicki, L., Chalmers, L., & Gee, P. R. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003559 · Cited by 26
Discordance of Self-report and Laboratory Measures of HIV Viral Load Among Young Men Who Have Sex with Men and Transgender Women in Chicago: Implications for Epidemiology, Care, and Prevention
Mustanski, B. S., Ryan, D. T., Remble, T. A., D’Aquila, R. T., Newcomb, M. E., & Morgan, E. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2112-7 · Cited by 27
“Response options ranged from past week to never missing a dose [30].”
Relationship between adherence and health-related quality of life among HIV-patients in South Africa: findings and implications
Vagiri, R. V., Johanna, C. M., Brian, G., & Andries (2018) · Journal of AIDS and HIV Research · doi:10.5897/jahr2018.0478 · Cited by 25
“Questions included in the socio-demographic questionnaire were based on previous studies conducted at Tshepang Clinic (Mapetla, 2007; Engelbrecht, 2010; Meyer et al., 2012), as well as with consideration of the literature (Belak Kovaĉević et al., 2006; Hasanah et al., 2010).”
Method
World Health Organization dimensions of adherence to antiretroviral therapy: A study at antiretroviral therapy centre, Aligarh
Alvi, Y., Khalique, N., Ahmad, A., Khan, H. S., & Faizi, N. (2019) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_164_18 · Cited by 26
Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework
Dima, A. L., Allemann, S. S., Dunbar‐Jacob, J. M., Hughes, D. A., Vrijens, B., & Wilson, I. B. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15375 · Cited by 27
“Some count-based measures also collect information on the type of medication prescribed and the recommended use timeline.(33,34) Estimation recall is influenced by the natural tendency to recall most recent events and telescope backwards in time and by the natural tendency to summarize events based on usual patterns(3…”
Background
Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly)
Murphy, D. A., Marelich, W. D., Rappaport, N. B., Hoffman, D., & Farthing, C. (2007) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109707301243 · Cited by 26
“Three measures of adherence to antiretroviral medications were obtained using the Adult AIDS Clinical Trials Group (AACTG) Adherence Baseline Questionnaire.(24) Respondents were asked to report the following for each of their antiretroviral medications: (1) name of drug, (2) prescribed doses per day, (3) prescribed nu…”
Method
Retrospective Study on the Critical Factors for Retaining Patients on Antiretroviral Therapy in KwaZulu-Natal, South Africa
Vella, V., Govender, T., Dlamini, S. S., Taylor, M., Moodley, I., David, V., & Jinabhai, C. C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e7744e · Cited by 26
Preferential Adherence to Immunosuppressive Over Nonimmunosuppressive Medications in Kidney Transplant Recipients
Terebelo, S., & MARKELL, M. S. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.08.027 · Cited by 26
Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds
Gwadz, M. V., Leonard, N. R., Nakagawa, A., Cylar, K., Finkelstein, M. S., Herzog, N., Tharaken, M., & Mildvan, D. (2006) · AIDS Care · doi:10.1080/09540120500428952 · Cited by 26
“However, although substance use appears associated with poor anti-retroviral medication adherence at a global level (Arnsten et al., 2002; Chesney et al., 2000), adherence is difficult to predict in individuals (Gross et al., 2002).”
Background
Efficacy of Interventions for Improving Antiretroviral Therapy Adherence in HIV/AIDS Cases at PIMS, Islamabad
Uzma, Q., Emmanuel, F., Ather, U., & Zaman, S. (2011) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109710383175 · Cited by 26
“However, if any dose was missed during last 90 days, it was taken as 95% SRA and if any dose was missed during last >90 days, it was taken as 97% SRA.(6) To increase the validity of SRA, a preamble was used before asking adherence questions to reassure patients that the information would not be held against them and t…”
MethodInfluential
The Influence of Different Types of Alcoholic Beverages on Disrupting Highly Active Antiretroviral Treatment (HAART) Outcome
Míguez‐Burbano, M. J., Lewis, J. E., Fishman, J. E., Asthana, D., & Malow, R. M. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp024 · Cited by 26
Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir
Townsend, K., Petersen, T. L., Gordon, L. A., Kohli, A., Nelson, A. K., Seamon, C., Gross, C., Tang, L., Osinusi, A. O., Polis, M. A., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000903 · Cited by 26
“com/ QAD/A785), modified appropriately to be applicable for patients infected with HCV [20].”
Background
Exposure to Violence and Virologic and Immunological Outcomes Among Youth With Perinatal HIV in the Pediatric HIV/AIDS Cohort Study
Kacanek, D., Malee, K., Mellins, C. A., Tassiopoulos, K., Smith, R. A., Grant, M., Lee, S., Siddiqui, D., & Puga, A. M. (2016) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.03.004 · Cited by 28
Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence
Santos, M. D., Lange, M., Gervais, R., Clarisse, B., Capel, A., Barillet, M., Grellard, J., Heutte, N., Licaj, I., & Joly, F. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-4644-4 · Cited by 27
The effect of male involvement and a prevention of mother-to-child transmission (PMTCT) intervention on depressive symptoms in perinatal HIV-infected rural South African women
Peltzer, K., Abbamonte, J. M., Mandell, L. N., Rodriguez, V. J., Lee, T. K., Weiss, S. M., & Jones, D. L. (2019) · Archives of Women s Mental Health · doi:10.1007/s00737-019-00955-7 · Cited by 30
What is a missed dose? Implications for construct validity and patient adherence
Sankar, A., Nevedal, D. C., Neufeld, S. W., & LUBORSKY, M. R. (2006) · AIDS Care · doi:10.1080/09540120600708501 · Cited by 26
“In slightly different ways, some asked for doses missed or skipped in the last 2 4 days (Chesney et al., 2000; Kimmerling et al., (2003); Moss et al., 2004; Oyugi et al., 2004; Wagner, 2002; Walsh et al., 2002; Weaver et al., 2005).”
Background
Evaluation of Adherence to Antiretroviral Therapy in Italian HIV Patients
Dorz, S., Lazzarini, L., Cattelan, A. M., Meneghetti, F., Novara, C., Concia, E., Sica, C., & Sanavio, E. (2003) · AIDS Patient Care and STDs · doi:10.1089/108729103321042890 · Cited by 26
Impact of Hepatitis C on HIV Progression in Adults With Alcohol Problems
Cheng, D. M., Nunes, D., Libman, H., Vidaver, J., Alperen, J. K., Saitz, R., & Samet, J. H. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00381.x · Cited by 26
“Potential Confounding Factors Adherence to antiretroviral medications was determined using the AIDS Clinical Trials Group Questionnaire for Adherence to Anti-Retroviral Medications (Chesney et al., 2000).”
Method
Assessing treatment motivation among patients receiving antiretroviral therapy: A multidimensional approach
Houston, E., McKirnan, D. J., Cervone, D., Johnson, M., & Sandfort, T. G. M. (2011) · Psychology and Health · doi:10.1080/08870446.2011.618536 · Cited by 25
“Self-reported adherence was assessed with the AIDS Clinical Trials Group (ACTG) adherence questionnaire (Chesney et al., 2000).”
Method
Adherence to Medical Regimens
Frain, M. P., Bishop, M. L., Tschopp, M. K., Ferrin, J. M., & Frain, J. (2009) · Rehabilitation Counseling Bulletin · doi:10.1177/0034355209333334 · Cited by 24
Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials
DeWorsop, D. O., Creatura, G. M., Bluez, G., Thurnauer, H., Forselius-Bielen, K., Ranganathan, M., Deaso, E., Bhat, J. A., & D’Souza, D. C. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.045 · Cited by 25
Effect of Zinc Supplementation vs Placebo on Mortality Risk and HIV Disease Progression Among HIV-Positive Adults With Heavy Alcohol Use
Freiberg, M. S., Cheng, D. M., Gnatienko, N., Blokhina, E. A., Coleman, S. M., Doyle, M. F., Yaroslavtseva, T. V., Bridden, C. L., So‐Armah, K., Tracy, R. P., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4330 · Cited by 25
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use
Tindle, H. A., Freiberg, M. S., Cheng, D. M., Gnatienko, N., Blokhina, E. A., Yaroslavtseva, T. V., Bendiks, S., Patts, G. J., Hahn, J. A., So‐Armah, K., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.25129 · Cited by 25
Adherence to highly active antiretroviral therapy in Spain. A meta-analysis
Ortego, C., Huedo-Medina, T. B., Vejo, J., & Llorca, F. J. (2011) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2010.10.016 · Cited by 25
Community HIV Treatment Advocacy Programs May Support Treatment Adherence
Bogart, L. M., Wagner, G. J., Mutchler, M. G., Risley, B., McDavitt, B., McKay, T., & Klein, D. J. (2012) · AIDS Education and Prevention · doi:10.1521/aeap.2012.24.1.1 · Cited by 25
“…measure of adherence self-efficacy: On a scale from 0 to 10, participants indicated how confident they were that they could follow their ART dosing instructions exactly as prescribed, with labels 0, Cannot do at all; 5, Moderately certain I can do; and 10, Certain I can do (Chesney et al. 2000).”
Background
Mental Health and Substance Use Among Patients in a North Carolina HIV Clinic
Skalski, L. M., Watt, M. H., MacFarlane, J. C., Proeschold‐Bell, R. J., Stout, J. E., & Sikkema, K. J. (2015) · North Carolina Medical Journal · doi:10.18043/ncm.76.3.148 · Cited by 25
“com 150 mine the last time they had missed taking their HIV ARV medication, if they were prescribed ARV therapy [19].”
Background
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
Akiyama, M. J., Agyemang, L. S., Arnsten, J. H., Heo, M., Norton, B. L., Schackman, B. R., Linas, B. P., & Litwin, A. H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-2964-5 · Cited by 25
“Selfreported adherence was measured using a modified AIDS Clinical Trials questionnaire adapted for IFN, RBV and DAAs, as well as a single-item visual analogue scale (VAS) which has been shown to correlate well with both pill counts and virological outcomes in HIV-infected patients taking ART [31, 32].”
Influential
Discrepancies between self-report and objective measures for stimulant drug use in HIV: Cognitive, medication adherence and psychological correlates
Reinhard, M. J., Hinkin, C. H., Barclay, T. R., Levine, A. J., Marion, S., Castellon, S. A., Longshore, D. L., Newton, T. F., Durvasula, R., Lam, M. N., et al. (2007) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.04.006 · Cited by 23
“For self-reported adherence we used a modified form of an adherence questionnaire developed by the adult AIDS Clinical Trials Group (ACTG) (Chesney et al., 2000a).”
MethodInfluential
Adherence to Antiretroviral Therapy Among Women With HIV Infection
Erlen, J. A., Sereika, S. M., Cook, R. L., & Hunt, S. C. (2002) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2002.tb00070.x · Cited by 25
Association of Adherence toMycobacterium aviumComplex Prophylaxis and Antiretroviral Therapy with Clinical Outcomes in Acquired Immunodeficiency Syndrome
Cohn, S. E., Kammann, E., Williams, P. L., Currier, J. S., & Chesney, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/339542 · Cited by 25
“the trial staff assisted patients, when necessary, by clarifying instructions or reading the questions when requested by participants [11].”
BackgroundSelf-citation
Applying an Expanded Social Determinant Approach to the Concept of Adherence to Treatment: The Case of Colombian Women Living With HIV/AIDS
Arrivillaga, M., Ross, M. W., Useche, B., Springer, A. E., & Correa, D. (2010) · Women s Health Issues · doi:10.1016/j.whi.2010.09.003 · Cited by 23
Lessons learned from an HIV adherence pilot study in the Deep South
Konkle‐Parker, D. J., Erlen, J. A., & Dubbert, P. M. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.04.010 · Cited by 24
Development of an Electronic Medical Record Based Alert for Risk of HIV Treatment Failure in a Low-Resource Setting
Puttkammer, N. H., Zeliadt, S. B., Balan, J. G., Baseman, J. G., Destiné, R., Domerçant, J. W., France, G., Hyppolite, N., Pelletier, V., Raphael, N. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112261 · Cited by 23
“However, measuring ART adherence is a challenge [3].”
Background
Physician Estimate of Antiretroviral Adherence in India: Poor Correlation with Patient Self-Report and Viral Load
Walshe, L., Saple, D. G., Mehta, S. H., Shah, B. B., Bollinger, R. C., & Gupta, A. (2010) · AIDS Patient Care and STDs · doi:10.1089/apc.2009.0208 · Cited by 24
A couple-based HIV prevention intervention for Latino men who have sex with men: study protocol for a randomized controlled trial
Martínez, O., Fernandez, M. I., Wu, E., Carballo‐Diéguez, A., Prado, G. J., Davey, A., Levine, E. C., Mattera, B., Lopez, N., Valentin, O., et al. (2018) · Trials · doi:10.1186/s13063-018-2582-y · Cited by 25
“These measures include missed dose counts, a visual analog scale [12], and validated AIDS Clinical Trials Group adherence measures [13].”
Method
Feasibility, acceptability, and preliminary impact of telemedicine-administered cognitive behavioral therapy for adherence and depression among African American women living with HIV in the rural South
Junkins, A., Psaros, C., Ott, C., Azuero, A., Lambert, C. C., Cropsey, K. L., Savage, R., Haberer, J. E., Safren, S. A., & Kempf, M.-C. (2020) · Journal of Health Psychology · doi:10.1177/1359105320926526 · Cited by 24
“Viral load suppression ( 200 copies/ml), the AIDS Clinical Trial Group (ACTG) ART adherence survey (Chesney et al., 2000), and the Wisepill device were used to evaluate ART adherence.”
Method
SANKOFA
Reynolds, N. R., Ofori-Atta, A. L., Lartey, M. Y., Renner, L. A., Antwi, S., Enimil, A. K., Catlin, A. C., Fernando, S., Kyriakides, T. C., & Paintsil, E. (2015) · AIDS · doi:10.1097/qad.0000000000000725 · Cited by 24
“Social support (caregiver) Social Provisions Questionnaire (SPS) [31] HIV knowledge (caregiver) HIV knowledge (HIV-KQ-18) [32] Illness perceptions (caregiver) Illness perceptions (Brief IPQ) [33] Perceived stigma (caregiver) HIV stigma scale [34] Depressive symptoms (caregiver and child) Beck Depression Inventory (BDI…”
Background
Exploring the Contribution of General Self-Efficacy to the Use of Self-Care Symptom Management Strategies by People Living with HIV Infection
Corless, I. B., Wantland, D. J., Kirksey, K. M., Nicholas, P. K., Human, S. P., Arudo, J., Rosa, M. E., Cuca, Y. P., Willard, S., Hamilton, M. J., et al. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0404 · Cited by 24
“26,27 The revised scale consists oftwo factors with a total of nineitems(pill-taking problems [5 items] and forgetfulness [4 items]) using a four point Likert-type scale ranging from 0 = never to 3 = often.”
Antiretroviral Drug Diversion Links Social Vulnerability to Poor Medication Adherence in Substance Abusing Populations
Tsuyuki, K., & Surratt, H. L. (2015) · AIDS and Behavior · doi:10.1007/s10461-014-0969-7 · Cited by 24
“Second, percent ARV adherence was measured using the ACTG instrument [31], which assessed self-reported adherence in the past 7 days.”
Utility of an Interactive Voice Response System to Assess Antiretroviral Pharmacotherapy Adherence Among Substance Users Living with HIV/AIDS in the Rural South
Tucker, J. A., Simpson, C. A., Huang, J., Roth, D. L., & Stewart, K. E. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0322 · Cited by 24
Quantitative Evaluation of an Instrument to Identify Chronic Pain in HIV-Infected Individuals
Merlin, J. S., Westfall, A. O., Chamot, E., Saag, M. S., Walcott, M. M., Ritchie, C. S., & Kertesz, S. G. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0362 · Cited by 24
Adherence to Varenicline Among African American Smokers: An Exploratory Analysis Comparing Plasma Concentration, Pill Count, and Self-report
Scheuermann, T. S., Berg, C. J., Cox, L. S., Nazir, N., Benowitz, N. L., Yu, L., Yturralde, O., Jacob, P., Choi, W. S., Ahluwalia, J. S., et al. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr333 · Cited by 24
Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica.
Harvey, K. M., Carrington, D., Duncan, J. P., Figueroa, J., Hirschhorn, L. R., Manning, D., & Jackson, S. (2008) · PubMed · Cited by 24
Physical and sexual violence and health care utilization in HIV-infected persons with alcohol problems
Liebschutz, J. M., Geier, J. L., Horton, N. J., Chuang, C.-H., & Samet, J. H. (2005) · AIDS Care · doi:10.1080/09540120512331314358 · Cited by 24
“Adherence was determined with the AIDS Clinical Trials Group (ACTG) Questionnaire for Adherence to Anti-Retroviral Medications(Chesney et al., 2000).”
Method
Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals
Shuper, P. A., Joharchi, N., Irving, H. M., Fletcher, D., Kovacs, C. C., Loutfy, M. R., Walmsley, S. L., Wong, D., & Rehm, J. T. (2016) · AIDS Care · doi:10.1080/09540121.2016.1158396 · Cited by 24
“Analyses were performed using ≥90%, ≥95%, and 100% cut-offs for both the 4-day ACTG measure and the 1- month VAS.”
MethodInfluential
Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries
Wanyama, J., Tsui, S., Kwok, C., Wanyenze, R. K., Denison, J. A., Koole, O., van Praag, E., Castelnuovo, B., Wabwire‐Mangen, F., Kwesigabo, G., et al. (2017) · International Journal of STD & AIDS · doi:10.1177/0956462416685890 · Cited by 24
Prospective State and Trait Predictors of Daily Medication Adherence Behavior in HIV
Cook, P. F., Schmiege, S. J., Starr, W., Carrington, J. M., & Bradley‐Springer, L. A. (2017) · Nursing Research · doi:10.1097/nnr.0000000000000216 · Cited by 26
“However, this preliminary study of state versus trait effects differed frommost ART adherence studies in at least two important ways: First, the measure of adherence was behavioral, whereas most of the older studies have used self-report instruments, such as the AIDS Clinical Trials Group Adherence Scale (Chesney et a…”
Adherence to HIV Medications in a Cohort of Men Who Have Sex With Men: Impact of September 11th
Halkitis, P. N. (2003) · Journal of Heredity · doi:10.1093/jurban/jtg161 · Cited by 24
Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia
Santoleri, F., Lasala, R., Logreco, A., Ranucci, E., & Costantini, A. (2018) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155218759184 · Cited by 23
Trajectories of Depressive Symptoms Among a Population of HIV-Infected Men and Women in Routine HIV Care in the United States
Bengtson, A. M., Pence, B. W., Powers, K. A., Weaver, M. A., Mimiaga, M. J., Gaynes, B. N., O’Cleirigh, C. M., Christopoulos, K., Mathews, W. C., Crane, H. M., et al. (2018) · AIDS and Behavior · doi:10.1007/s10461-018-2109-2 · Cited by 23
“CNICS PROs include validated measures of ART adherence (Adult AIDS Clinical Trials Unit Adherence Instrument, defined as no missed doses in the past week [37]), panic disorder (PHQ5, defined as none, some panic disorder symptoms, or panic disorder over the last 4 weeks [38]), high risk alcohol use over the last year (…”
Method
Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons
Vyas, K. J., Limneos, J., Qin, H., & Mathews, W. C. (2014) · AIDS Care · doi:10.1080/09540121.2014.882486 · Cited by 25
Alcohol use and HIV disease management: The impact of individual and partner-level alcohol use among HIV-positive men who have sex with men
Woolf‐King, S. E., Neilands, T. B., Dilworth, S. E., Carrico, A. W., & Johnson, M. O. (2013) · AIDS Care · doi:10.1080/09540121.2013.855302 · Cited by 24
“Adherence was assessed using the adherence measure developed by the AIDS Clinical Trials Group (Chesney et al., 2000), which provides detailed information about adherence over the prior three days and the visual analog scale developed by Walsh, Pozniak, Nelson, Mandalia and Gizzard (2002) to assess…”
Method
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
Josephson, F., Andersson, M. C. H., Flamholc, L., Gisslén, M., Hagberg, L., Ormaasen, V., Sönnerborg, A. B., Vesterbacka, J., & Böttiger, Y. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0763-z · Cited by 23
Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS
Kudel, I., Farber, S. L., Mrus, J. M., Leonard, A. C., Sherman, S. N., & Tsevat, J. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00645.x · Cited by 23
Antiretroviral Non-Adherence is Associated With a Retrieval Profile of Deficits in Verbal Episodic Memory
Obermeit, L. C., Morgan, E. E., Casaletto, K. B., Grant, I., Woods, S. P., & the HIV Neurobehavioral Research Program (HNRP) Group (2015) · The Clinical Neuropsychologist · doi:10.1080/13854046.2015.1018950 · Cited by 23
Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam
Hương, D. T., Bannister, W. P., Phong, P. T., Kirk, O., & Peters, L. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.010515 · Cited by 23
Depression and Survival in a 17-Year Longitudinal Study of People With HIV: Moderating Effects of Race and Education
Ironson, G. H., Fitch, C., & Stuetzle, R. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000488 · Cited by 23
Prevalence and Factors Associated with Fixed-Dose Combination Antiretroviral Drugs Adherence among HIV-Positive Pregnant Women on Option B Treatment in Mpumalanga Province, South Africa
Ramlagan, S., Peltzer, K., Ruiter, R. A. C., Barylski, N. A., Weiss, S. M., & Sifunda, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010161 · Cited by 23
A qualitative study on alcohol consumption and HIV treatment adherence among men living with HIV in Ugandan fishing communities
Sileo, K. M., Kizito, W., Wanyenze, R. K., Chemusto, H., Musoke, W., Mukasa, B., & Kiene, S. M. (2018) · AIDS Care · doi:10.1080/09540121.2018.1524564 · Cited by 23
“Alcohol use results in lower CD4 counts, increases disease progression, and further weakens the immune system of PLHIV (Hahn & Samet, 2010).”
BackgroundInfluential
Measuring Adolescent HIV Self-management: An Instrument Development Study
Crowley, T., van der Merwe, A. S., Kidd, M., & Skinner, D. G. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02490-z · Cited by 23
Substance use and its effect on antiretroviral treatment adherence among male fisherfolk living with HIV/AIDS in Uganda
Sileo, K. M., Kizito, W., Wanyenze, R. K., Chemusto, H., Reed, E., Stockman, J. K., Musoke, W., Mukasa, B., & Kiene, S. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216892 · Cited by 23
Comparación de tres métodos de cálculo de adherencia en pacientes con tratamiento antirretroviral
Codina, C., Martínez, M., Tuset, M., del Cacho, E., Martín, M. T., Miró, J. M., Mallolas, J., de Lazzari, E., García, F., Martínez, E., et al. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72850-4 · Cited by 23
Motivational interviewing and problem-solving therapy intervention for patients on antiretroviral therapy for HIV in Tshwane, South Africa: A randomized controlled trial to assess the impact on alcohol consumption
Parry, C. D. H., Myers, B., Londani, M., Shuper, P. A., Janse van Rensburg, C., Manda, S. O. M., Nkosi, S., Kekwaletswe, C. T., Hahn, J. A., Rehm, J., et al. (2023) · Addiction · doi:10.1111/add.16278 · Cited by 22
“…which assesses patients ’ current ART medications, dosing schedule and medication doses missed over the past 4 days (< 95% = poor adherence) [17]; (2) the Visual Analogue Scale (VAS), which assesses general levels of adherence over a 30-day time-frame (< 95% = poor adherence) [18]; (3) the…”
Background
Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia
Uusküla, A., Laisaar, K.-T., Raag, M., Šmidt, J., Semjonova, S., Kogan, J., Amico, K. R., Sharma, A., & DeHovitz, J. A. (2012) · AIDS Care · doi:10.1080/09540121.2012.672724 · Cited by 22
A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care
Samet, J. H., Blokhina, E. A., Cheng, D. M., Walley, A. Y., Lioznov, D. A., Gnatienko, N., Quinn, E. K., Bridden, C. L., Chaisson, C. E., Toussova, O., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002230 · Cited by 22
Self-citation
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial
Korthuis, P. T., King, C. A., Cook, R., Khuyen, T. T., Kunkel, L. E., Bart, G. B., Nguyen, T. D., Thuy, D. T., Bielavitz, S., Nguyen, D. B., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(20)30302-7 · Cited by 23
Forgetting to take HIV antiretroviral therapy: a qualitative exploration of medication adherence in the third decade of the HIV epidemic in the United States
Freeman, R., Gwadz, M. V., Francis, K. L., & Hoffeld, E. (2021) · SAHARA-J Journal of Social Aspects of HIV/AIDS · doi:10.1080/17290376.2021.1989021 · Cited by 22
“Although forgetting as a barrier to optimal ART adherence has been well documented in the empirical literature (Barfod et al., 2006; Chesney et al., 2000; Marecek, Fine, & Kidder, 2001; Sauceda et al., 2018), it has rarely been explored qualitatively.”
Background
Implementation and Operational Research
Ochieng, W., Kitawi, R. C., Nzomo, T. J., Mwatelah, R. S., Kimulwo, M. J., Ochieng, D. J., Kinyua, J., Lagat, N. J., Onyango, K., Lwembe, R., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000580 · Cited by 22
Development and Implementation of a Medication Adherence Training Instrument for Persons Living With HIV
McPherson-Baker, S., Jones, D. L., Durán, R. E., Klimas, N. G., & Schneiderman, N. (2005) · Behavior Modification · doi:10.1177/0145445504272604 · Cited by 22
Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana
Toledo, L., McLellan–Lemal, E., Henderson, F. L., & Kebaabetswe, P. M. (2015) · World Journal of AIDS · doi:10.4236/wja.2015.51002 · Cited by 22
“13 Trials Group (AACTG) Adherence Questionnaire [17], which researchers collected at each monthly visit through a face-to-face interview for the 36-month trial duration.”
Method
Asking about adherence – from flipping the coin to strong evidence
Glass, T. R., & Cavassini, M. L. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14016 · Cited by 22
Pharmacy and Self-Report Adherence Measures to Predict Virological Outcomes for Patients on Free Antiretroviral Therapy in Tamil Nadu, India
McMahon, J. H., Manoharan, A., WANKE, C. A., Mammen, S., Jose, H., Malini, T., Kadavanu, T. M., Jordan, M. R., Elliott, J., Lewin, S. R., et al. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0436-x · Cited by 22
Drinking Motives Among HIV Primary Care Patients
Elliott, J. C., Aharonovich, E., O’Leary, A., Wainberg, M. L., & Hasin, D. S. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0644-4 · Cited by 21
“using the AIDS risk assessment scale [54], and whether patients had taken all of their medication in the past four days using a 4-day adaptation of the Adult AIDS clinical trials group adherence instruments [55].”
MAHILA: a protocol for evaluating a nurse-delivered mHealth intervention for women with HIV and psychosocial risk factors in India
Reynolds, N. R., Satyanarayana, V. A., Duggal, M., Varghese, M., Liberti, L. S., Singh, P., Ranganathan, M., Jeon, S., & Chandra, P. S. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1605-1 · Cited by 22
Social Support and the Mediating Roles of Alcohol Use and Adherence Self-Efficacy on Antiretroviral Therapy (ART) Adherence Among ART Recipients in Gauteng, South Africa
Kekwaletswe, C. T., Jordaan, E., Nkosi, S., & Morojele, N. K. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1595-3 · Cited by 22
Do peer support groups have an effect on medication adherence? A study among people living with HIV/AIDS in Enugu State, Nigeria
Chime, O. H., Arinze-Onyia, S. U., & Obionu, C. N. (2018) · Proceedings of Singapore Healthcare · doi:10.1177/2010105818760923 · Cited by 22
A Task-Shifting Problem-Solving Therapy Intervention for Depression and Barriers to Antiretroviral Therapy Adherence for People Living With HIV in Zimbabwe: Case Series
Nyamayaro, P. C., Bere, T. C., Magidson, J. F., Simms, V. M., O’Cleirigh, C. M., Chibanda, D., & Abas, M. (2019) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2018.10.003 · Cited by 26
Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation
Heller, D. J., Balzer, L. B., Kazi, D. S., Charlebois, E. D., Kwarisiima, D., Mwangwa, F., Jain, V., Kotwani, P., Chamie, G., Cohen, C. R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0222801 · Cited by 22
“medication adherence by 3-day recall in person at every clinic visit–this approach was designed to mirror medication adherence instruments validated for HIV care with which clinic staff were already familiar [41].”
Method
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression
Gulick, R. M., Lalama, C. M., Ribaudo, H. J., Shikuma, C. M., Schackman, B. R., Schouten, J. T., Squires, K., Koletar, S. L., Pilcher, C. D., Reichman, R. C., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32805e8753 · Cited by 22
“An adherence questionnaire [26] was either self-administered by the subject or completed by the subject with the assistance of the study coordinator every 24 weeks.”
Method
A Pilot Trial of Indinavir, Ritonavir, Didanosine, and Lamivudine in a Once-Daily Four-Drug Regimen for HIV Infection
Mole, L. A., Schmidgall, D., & Holodniy, M. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200107010-00007 · Cited by 22
Adherence to Highly Active Antiretroviral Treatment in HIV-Infected Rwandan Women
Musiime, S., Muhairwe, F., Rutagengwa, A., Mutimura, E., Anastos, K., Hoover, D. R., Qiuhu, S., Munyazesa, E., Emile, I., Uwineza, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027832 · Cited by 21
Effect of varenicline directly observed therapy versus varenicline self‐administered therapy on varenicline adherence and smoking cessation in methadone‐maintained smokers: a randomized controlled trial
Nahvi, S., Adams, T. R., Ning, Y. M., Zhang, C., & Arnsten, J. H. (2020) · Addiction · doi:10.1111/add.15240 · Cited by 21
“However, even smokers in treatment for OUD experience challenges adhering to smoking cessation pharmacotherapy, including: comorbid disease (10), limited social support (11,12), poor self-efficacy (13,14), and risk perceptions that prioritize other medical concerns over tobacco-related risks (15).”
Background
Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review
Fahrni, M. L., Saman, K. M., Alkhoshaiban, A. S., Naimat, F., Ramzan, F., & Isa, K. A. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057868 · Cited by 24
Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics
Litwin, A. H., Berg, K. M., Li, X., Hidalgo, J., & Arnsten, J. H. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-315 · Cited by 21
“Long ACASI survey includes measures of: adherence [33]; opiate withdrawal [34]; on-site social support; depression (BDI-II and PHQ-9)[39-41];”
BackgroundMethod
The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients
Garvey, L. J., Latch, N., Erlwein, O. W., Mackie, N., Walsh, J. J., Scullard, G. H., McClure, M. O., Dickinson, L., Back, D. J., & Winston, A. (2010) · Antiviral Therapy · doi:10.3851/imp1517 · Cited by 21
Differences in adherence and motivation to HIV therapy—two independent assessments in 1998 and 2002
Södergård, B., Halvarsson, M., Lindbäck, S., Sönnerborg, A. B., Tully, M. P., & Lindblad, Å. K. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9036-4 · Cited by 21
Patient factors impacting antiretroviral drug adherence in a Nigerian tertiary hospital.
Falang, K. D., Akubaka, P., & Jimam, N. (2012) · Europe PMC (PubMed Central) · doi:10.4103/0976-500x.95511 · Cited by 21
“Other approaches involve provider estimation and measurement of plasma drug concentration.[5]”
BackgroundResultInfluential
Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project
Been, S. K., van de Vijver, D. A. M. C., Nieuwkerk, P. T., Brito, I., Stutterheim, S. E., Bos, A. E. R., Wolfers, M. E. G., Pogány, K., & Verbon, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162800 · Cited by 21
“The final item measured the most recent missed dose: Q4: ‘When was the last time you missed any of your anti-HIV medications?’ (answers scored on a 6-point Likert scale ranging from 1 = ‘within the past week’ to 6 = ‘never missed’)[26].”
Background
A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS
Brandt, C. P., Paulus, D. J., Garza, M. J., Lemaire, C. M., Norton, P. J., & Zvolensky, M. J. (2017) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2017.01.007 · Cited by 21
Stigma gets in my way: Factors affecting client-provider communication regarding childbearing among people living with HIV in Uganda
Beyeza‐Kashesya, J., Wanyenze, R. K., Goggin, K., Finocchario‐Kessler, S., Woldetsadik, M. A., Mindry, D. L., Birungi, J., & Wagner, G. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192902 · Cited by 21
Provider Perceptions of Hepatitis C Treatment Adherence and Initiation
Zhang, G., Patel, K., Moghe, A., Reid, A. E., Serper, M., Calgaro, L., Gibson, S. P., Zickmund, S. L., Shaikh, O. S., & Rogal, S. S. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05877-z · Cited by 21
“The survey was adapted from the AIDS Clinical Trial Group Adherence Questionnaire [17] using the additional potential barriers to treatment identified through our prior qualitative work [16].”
Method
Perceptions About the Acceptability of Assessments of HIV Medication Adherence in Lilongwe, Malawi and Chennai, India
Safren, S. A., Kumarasamy, N., Hosseinipour, M. C., Harwood, M. M., Hoffman, I., McCauley, M., Jumbe, A. N., Nyirenda, C., Mimiaga, M. J., Solomon, S., et al. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9094-6 · Cited by 21
Factors Associated with Non-Adherence to HBV Antiviral Therapy
Sheppard‐Law, S., Zablotska, I., Kermeen, M., Holdaway, S., Lee, A. M., George, J., Zekry, A., & Maher, L. (2017) · Antiviral Therapy · doi:10.3851/imp3219 · Cited by 21
“A recall time of 30 days was selected [20].”
Method
The Relationship Between Type and Quality of Social Support and HIV Medication Adherence
Hamilton, M. M., Razzano, L. A., & Martin, N. B. (2007) · Journal of HIV/AIDS & Social Services · doi:10.1300/j187v06n01_04 · Cited by 21
“Data aggregation was completed for nominal and ordinal variables where indicated, as well as to construct scales and total scores as instructed for the Norbeck and the ACTG adherence measures using procedures described in other published papers (Chesney et al., 2000; Gigliotti, 2002; Norbeck, Lindsey, & Carrieri, 1981…”
BackgroundMethodResultInfluential

Authors: Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE
Affiliations: University of California, San Francisco (US)
Yale University (US)
University of California San Diego (US)
The Ohio State University (US)
Indiana University Indianapolis (US)
Johns Hopkins University (US)
ORCID: Chesney, M. A.
Ickovics, J. R.
Gifford, A. L.
Wu, A. W.
Venue: AIDS Care
Publisher: Informa UK Limited
Published: 2000-06
Volume: 12
Issue: 3
Pages: 255-266
ISSN: 0954-0121 (ISSN-L)
1360-0451
DOI: 10.1080/09540120050042891
OpenAlex: W2088423598
Cited by: 1,428
References: 12
Citations by year: 2026: 14 · 2025: 28 · 2024: 29 · 2023: 29 · 2022: 40 · 2021: 53 · 2020: 51 · 2019: 55 · 2018: 61 · 2017: 66 · 2016: 67 · 2015: 76 · 2014: 81 · 2013: 84 · 2012: 74
FWCI: 27.22
Type: journal article
Language: en
Open access: closed
Locations: AIDS Care (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (P50-MH42459, P30MH059037, P50MH042459, P30-MH 59037)
National Institute of Allergy and Infectious Diseases (U01AI-38858, U01AI038858)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: antiretroviral therapy adherence, HIV, self-report questionnaire, medication non-adherence, adherence self-efficacy, alcohol consumption, protease inhibitors, clinical trial participants, questionnaire development
MeSH terms: Adult, Alcohol Drinking, Clinical Trials as Topic, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Compliance, Pilot Projects, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, HIV Infections, Anti-HIV Agents, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks